Functional Milk...นม (ทางเลือก) นี้ดีหรือไม่


  • พรพิมล นันท์ธนะวานิช นักกำหนดอาหารวิชาชีพ โรงพยาบาลบีเอ็นเอช


No available


Download data is not yet available.


Diawkee T. ตั้งเป้าใหม่คนไทยดื่มนมเพิ่มเป็น 25 ลิตร/คน/ปี. สำนักงานกองทุนสนับสนุนการสร้างเสริมสุขภาพ [Internet]. 2018 [Accessed Nov 6,2018]; Available from: URL:ตั้งเป้าใหม่คนไทยดื่มนมเพิ่มเป็น 25 ลิตร/คน/ปี.html

Niki R KG, Kimura T, Takahashi K, Koyama K, Nishinari K. Physical properties and microstructure of rennet gels from casein micelles of different sizes.

Milchwissenschaft. 1994;49:325-29.

CNS M. Beta-casein A1, ischemic heart diseases, mortality and other illnesses. Med Hypotheses. 2001; 56:262-72.

Miller GD, Jarvis JK, McBean LD. The Importance of Milk and Milk Products in the Diet In: Handbook of Dairy Foods and Nutrition Third Edition [Wolinsky I,

editor]. Boca Raton, Florida, USA CRC Press; 2007.

Haq MRU, Kapila R, Saliganti V. Consumption of β-casomorphins-7/5 induce inflammatory immune response in mice gut through Th2 pathway. J Funct Foods. 2014;8:150-60.

Haq MRU, Kapila R, Sharma R, Saliganti V, Kapila S. Comparative evaluation of cow β-casein variants (A1/A2) consumption on Th 2-mediated inflammatory

response in mouse gut. Eur J Nutr. 2014;53(4):1039-49.

Brooke-Taylor S, Dwyer K, Woodford K, Kost N. Systematic Review of the Gastrointestinal Effects of A1 Compared with A2 β-Casein. Adv Nutr. 2017;8(5):739-48.

Priyadarshini P, Mishra C, Mishra B, Swain K, Rout M, Mishra SP. Impact of milk protein on human health: A1 verses A2. Int J Cosmet Sci. 2018;6(1):531-5.

Jarmolowska B, Sidor K, Iwan M, Bielikowicz K,Kaczmarski M, Kostyra E, et al. Changes of β-casomorphin content in human milk during lactation.Peptides. 2007;28(10):1982-6.

Ng-Kwai-Hang KF GFIFPa, (eds). MP. Genetic polymorphism of milk proteins. Advances Dairy Chemistry.2002(16):737-814.

HE S. Protein and amino acid composition of bovine milk. In: Jensen RG, editor Handbook of milk composition Academic Press, USA. 1995:464-8.

Farrell Jr H, Jimenez-Flores R, Bleck G, Brown E,Butler J, Creamer L, et al. Nomenclature of the proteins of cowsû milk-Sixth revision. J Dairy Sci. 2004; 87(6):1641-74.

Truswell A. The A2 milk case: a critical review. Eur J Clin Nutr. 2005;59(5):623.

Kostyra E, Sienkiewicz-Szlapka E, Jarmolowska B, Krawczuk S, Kostyra H. Opioid peptides derived from milk proteins. Pol. J. Food Nutr. Sci. 2004;13(Suppl.1):25-35.

Birgisdottir BE, Hill J, Thorsson A, Thorsdottir I. Lower consumption of cow milk protein A1 β-casein at 2 years of age, rather than consumption among 11-to

-year-old adolescents, may explain the lower incidence of type 1 diabetes in Iceland than in Scandinavia. Ann Nutr Metab. 2006;50(3):177-83.

Laugesen M, Elliott R. Ischaemic heart disease, Type 1 diabetes, and cow milk A1 β-casein. NZ Med J.2003 Jan 24;116(1168):U295.2003.

Elliott R, Harris D, Hill J, Bibby N, Wasmuth H. Type I (insulin-dependent) diabetes mellitus and cow milk: casein variant consumption. Diabetologia. 1999; 42(3):


Swinburn B. Beta casein A1 and A2 in milk and human health. Report to New Zealand Food Safety Authority. 2004.

Dai YD, Marrero IG, Gros P, Zaghouani H, Wicker LS, Sercarz EE. Slc11a1 enhances the autoimmune diabetogenic T-cell response by altering processing and

presentation of pancreatic islet antigens. Diabetes. 2009;58(1):156-64.

Chia J, McRae J, Kukuljan S, Woodford K, Elliott R, Swinburn B, et al. A1 beta-casein milk protein and other environmental pre-disposing factors for type 1

diabetes. Nut Diabetes. 2017;7(5):e274.

Parashar A, Saini RK. A1 milk and its controversy-a review. Int J Bioassays. 2015;4(12):4611-9.

Chin-Dusting J, Shennan J, Jones E, Williams C, Kingwell B, Dart A. Effect of dietary supplementation with βcasein A1 or A2 on markers of disease development

in individuals at high risk of cardiovascular disease. Br J Nutr. 2006;95(1):136-44.

Venn B, Skeaff C, Brown R, Mann J, Green T. A comparison of the effects of A1 and A2 β-casein protein variants on blood cholesterol concentrations in New Zealand adults. Atherosclerosis. 2006;188(1):175-8.

Cade R, Privette M, Fregly M, Rowland N, Sun Z, Zele V, et al. Autism and schizophrenia: intestinal disorders. Nutr Neurosci. 2000;3(1):57-72.

Amaral DG, Schumann CM, Nordahl CW. Neuroanatomy of autism. Trends Neurosci. 2008;31(3):137-45.

Andreasen NC, Flaum M. Schizophrenia: the characteristic symptoms. Schizophr Bull. 1991;17(1):27-49.

Knivsberg A, Reichelt K, Høien T, Nødland M. A randomised, controlled study of dietary intervention in autistic syndromes. Nutr Neurosci. 2002;5(4):251-61.

Navarro F, Pearson DA, Fatheree N, Mansour R, Hashmi SS, Rhoads JM. Are ùleaky gutûand behavior associated with gluten and dairy containing diet in

children with autism spectrum disorders? Nutr Neurosci. 2015;18(4):177-85.

Millward C, Ferriter M, Calver SJ, Connell-Jones GG. Gluten-and casein-free diets for autistic spectrum disorder. Cochrane Database Syst Rev. 2008(2):


Beckwith JB. Defining the sudden infant death syndrome.Arch Ped Adolesc Med. 2003;157(3):286-90.

Wasilewska J, Sienkiewicz-Szlapka E, Kuzbida E, Jarmolowska B, Kaczmarski M, Kostyra E. The exogenous opioid peptides and DPPIV serum activity in

infants with apnoea expressed as apparent life threatening events (ALTE). Neuropeptides. 2011;45(3):189-95.

Sun Z, Zhang Z, Wang X, Cade R, Elmir Z, Fregly M. Relation of β-casomorphin to apnea in sudden infant death syndrome. Peptides. 2003;24(6):937-43.